Usually when I talk with someone about DE&I in pharma, the crux of the conversation revolves around the effects of better community engagement or empowering patients to be more knowledgeable about participating in clinical trials....
According to a new KLAS report, 58% of healthcare executives say their organization is likely to implement or purchase a solution within the next year. Larger organizations, particularly hospitals with more than 500 beds, are more inclined to invest in a solution than smaller organizations,...
The approval of yet another RNA-based vaccine for COVID-19 might not seem momentous. But the endorsement last week by Japanese authorities of a jab against SARS-CoV-2 constructed using a form of RNA that can make copies of itself inside cells — the first ‘self-amplifying’ RNA (saRNA) granted...
Elizabeth Hagerman, chief innovation officer at UW Health and executive director of the Isthmus Project, discusses her background and the Isthmus Project's efforts to help UW- and UW Health-affiliated entrepreneurs take healthcare innovations through the commercialization process....
The University of Wisconsin–Madison is rolling out a new system to make payment to research participants easier and more efficient....
The University of Wisconsin–Madison, for the first time, has topped $1.5 billion in research expenditures, according to the National Science Foundation. With this accomplishment, UW–Madison is ranked 8th among the nearly 900 public and private universities surveyed by NSF....
Lauren W. Yowelunh McLester-Davis, a University of Wisconsin–Madison neuroscientist and researcher, has joined the Native American Center for Health Professions (NACHP) in the UW School of Medicine and Public Health as its first director of Indigenous science advocacy....
The device that netted a foursome of University of Wisconsin-Madison biomedical engineering classmates a 2023 Wisconsin Innovation Award doesn’t look flashy. It’s a small plastic cylinder, just over 1.5 inches in length, with a spring-loaded clip in the middle....
While the challenges of cancer diagnosis, treatment, and survivorship are well-known, adolescents and young adults (AYAs), ages 15-39, have specific hurdles. What’s more, challenges that occur in this age group for clinical care are mirrored in clinical research, where a deficit of AYAs are represented....
Susannah is at the vanguard of a new movement in medicine: therapy so specialized it is designed for just a few patients, or even a single one. Such bespoke therapies are possible because of advances in medicine including gene therapy, the messenger RNA approach used...
